Understanding Testicular Cancer
Testicular Cancer is one of the most common types of cancer found in males in the United States between the age range of 30-50 years even though this form of cancer is quite rare when compared to other types of cancer. The testicle is a part of the male reproductive system and produces sperms and testosterone which is a sex hormone. The testicles are located within the scrotum which hangs just below the penis. Testicular Cancer is a condition which can be treated successfully even if it spreads to other parts, although the chances of complete recovery are much higher if it is diagnosed in its early stages.
A treatment plan for Testicular Cancer can be formulated depending on the stage of the cancer and how much it has spread. Survival rate of an individual with Testicular Cancer is something which throws some interesting facts.
How Long Can One Live With Testicular Cancer?
Coming to the survival rate of individuals with Testicular Cancer, the 5 year survival rate is approximately more than 95%. This percentage increases substantially if testicular cancer is diagnosed in its early stages. However, the percentage of survival rate dips slightly in cases where the cancer has spread to other parts of the body.
The 5 year survival rate for individuals with Testicular Cancer confined to the testicles is almost 100% with treatment. In cases where the cancer has spread to the retroperitoneal lymph nodes in the abdominal region, then the survival rate decreases slightly at about 94% depending on the size of the tumor cells.
In cases where the cancer has spread to beyond the testicular and abdominal area and erodes nearby vital organs then the 5 year survival rate for such individuals is about 70%.
All these data is a rough estimate and should not be taken as an exact number and these estimates change every year with more people getting diagnosed and treated for Testicular Cancer. Treating physician will be able to give a more realistic time frame on how long can the patient live with testicular cancer.